The Vector and Virus Core (Core C), previously named the Protein Interactions Core, was originally established to provide services for the expression of recombinant derived proteins in both prokaryotic and eukaryotic systems suitable for protein purification in-vitro and expression in-vivo, vector design and selection for in-vitro and in-vivo expression, biochemical characterization of protein interactions, (including FRET, split luciferase/GFP, and yeast two-hybrid screening systems), and generation of constructs for tandem affinity purification (TAP) and mass spectroscopy. The Core has evolved, responding to the needs of NINDS investigators and added new technologies to facilitate genetic and biochemical examination of biological systems. For example, the core produces 30-100 lentiviruses per year for shRNA expression. This prompted changing Core C name to the Vector and Virus Core. As the major theme of the Core C Laboratory is to accelerate genetic and biochemical studies of NINDS investigators by establishing new methodologies, Core C will implement services to provide lentiviral and AAV viruses for optogenetic probes, provide services for CRISPR/Cas 9 mediated gene editing, as well as continuing to provide services for protein interaction studies. The core also provides training to students, technicians, and post-doctoral fellows in molecular biology and virology. In addition, an added value of this core will be to foster collaborative interactions between NINDS supported investigators at UAB with similar research interests.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Center Core Grants (P30)
Project #
2P30NS047466-11A1
Application #
9192835
Study Section
Special Emphasis Panel (ZNS1)
Project Start
Project End
Budget Start
2016-06-01
Budget End
2017-05-31
Support Year
11
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Wadsworth, Heather M; Maximo, Jose O; Donnelly, Rebecca J et al. (2018) Action simulation and mirroring in children with autism spectrum disorders. Behav Brain Res 341:1-8
McMeekin, Laura J; Li, Ye; Fox, Stephanie N et al. (2018) Cell-Specific Deletion of PGC-1? from Medium Spiny Neurons Causes Transcriptional Alterations and Age-Related Motor Impairment. J Neurosci 38:3273-3286
Harms, Ashley S; Thome, Aaron D; Yan, Zhaoqi et al. (2018) Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease. Exp Neurol 300:179-187
Wang, Bing; Underwood, Rachel; Kamath, Anjali et al. (2018) 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic ?-Synuclein. J Neurosci 38:8211-8232
Rangarajan, Sunad; Bone, Nathaniel B; Zmijewska, Anna A et al. (2018) Metformin reverses established lung fibrosis in a bleomycin model. Nat Med 24:1121-1127
Arrant, Andrew E; Filiano, Anthony J; Patel, Aashka R et al. (2018) Reduction of microglial progranulin does not exacerbate pathology or behavioral deficits in neuronal progranulin-insufficient mice. Neurobiol Dis 124:152-162
Ramani, Manimaran; Kumar, Ranjit; Halloran, Brian et al. (2018) Supraphysiological Levels of Oxygen Exposure During the Neonatal Period Impairs Signaling Pathways Required for Learning and Memory. Sci Rep 8:9914
Bohannon, Andrew S; Hablitz, John J (2018) Developmental Changes in HCN Channel Modulation of Neocortical Layer 1 Interneurons. Front Cell Neurosci 12:20
Larson-Casey, Jennifer L; Gu, Linlin; Jackson, Patricia L et al. (2018) Macrophage Rac2 Is Required to Reduce the Severity of Cigarette Smoke-induced Pneumonia. Am J Respir Crit Care Med 198:1288-1301
Arrant, Andrew E; Nicholson, Alexandra M; Zhou, Xiaolai et al. (2018) Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency. Mol Neurodegener 13:32

Showing the most recent 10 out of 207 publications